DI BELLA METHOD
>
DOCUMENTATION INDEX > MDB - Documents
Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer.
(23/05/2003)
Detail
Synergistic anti-proliferative effects of vitamin D derivatives and 9-cis retinoic acid in SH-SY5Y human neuroblastoma cells.
(23/05/2003)
Detail
Lipid peroxidation is associated with the inhibitory action of all-trans-retinoic acid on mammary cell transformation.
(23/05/2003)
Detail
Proteolysis of integrin alpha5 and beta1 subunits involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells.
(23/05/2003)
Detail
The state-of-the-art in chemoprevention of skin cancer.
(23/05/2003)
Detail
Acute myelogenous leukemia with a t(2;17;4)(p13;q21;p16) aberration: effective treatment with all-trans retinoic acid and granulocyte colony-stimulating factor.
(23/05/2003)
Detail
Oral leukoplakia: open trial of topical therapy with calcipotriol compared with tretinoin.
(23/05/2003)
Detail
Plasma retinoid levels in head and neck cancer patients: a comparison with healthy controls and the effect of retinyl palmitate treatment.
(23/05/2003)
Detail
Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment.
(23/05/2003)
Detail
Reduced levels of retinyl esters and vitamin A in human renal cancers.
(23/05/2003)
Detail
The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer.
(23/05/2003)
Detail
All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
(23/05/2003)
Detail
All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1.
(23/05/2003)
Detail
All-trans retinoic acid modulates fas expression and enhances chemosensitivity of human medulloblastoma cells.
(23/05/2003)
Detail
The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid.
(23/05/2003)
Detail